Trial
NCT04329923
The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Ravi Amaravadi, MD
Collaborators
—
Condition
COVID-19
Intervention
Hydroxychloroquine Sulfate 400 mg twice a day
Why stopped
Cohort 1: slow accrual Cohort 2: Other studies showed no benefit Cohort 3: Study met pre-specificied futility analysis at planned second interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-10